Mr. Cui Hu, founder of Topscience Biotech, delivered a remarkable speech at the company's 20th-anniversary celebration: "Through twenty years of extraordinary journey, we have explored for survival and invested for development. The new journey lies at our feet. All colleagues must work together to break through the technological barriers in our field, develop into a shining star in the industry, and jointly unveil the splendid chapter of the next twenty years!"

Amid the rapid development of the global pharmaceutical raw materials industry, Pharmaceutical Grade Sodium Hyaluronate, as a core raw material for high-end medical devices and pharmaceuticals, has seen its quality standards and technological innovation become key measures of a company's core competitiveness. As global market demands for raw material purity, safety, and personalized customization increasingly rise, companies possessing international compliance qualifications, sustainable supply capabilities, and differentiated technological advantages are gradually transitioning from regional players to indispensable links in the global industrial chain.

Topscience Biotech, through its twenty-year commitment to quality and innovation, has successfully positioned itself as a key participant in the global supply chain for high-quality pharmaceutical raw materials.

 Persistent Cultivation, Establishing the "High-Quality" Industry Banner

For many years, Topscience Biotech has consistently adhered to its corporate mission of "working for the well-being of human health," achieving continuous critical breakthroughs in technological R&D and product iteration. Since its establishment in 2005, the company has undergone solid accumulation through capacity expansion and product upgrades; by 2015, its global certification system was gradually perfected; by 2023, Sterile Sodium Hyaluronate was successfully launched; and by 2025, Medical Device Grade Chondroitin Sulfate Sodium was smoothly introduced. The company has progressively built a robust technological barrier. This stems primarily from Topscience Biotech's unwavering persistence and focus.

Reviewing its growth path, from strategic transformation and capacity expansion to technological upgrades and global market layout, the concept of "high quality" has always been central, continuously solidifying the company's moat in the raw materials sector. This is precisely the key to earning long-term customer trust in the global medical aesthetics and pharmaceutical raw materials markets. Today, Topscience Biotech's business covers nearly 70 countries and regions worldwide, and its comprehensive strength is increasingly recognized by industry insiders:

1. Extreme Standards Craft High-End Raw Materials

Topscience Biotech has established a product matrix covering pharmaceuticals, medical aesthetics, and other fields, achieving industry-leading performance in key quality control indicators. Taking bacterial endotoxin control as an example, while the industry generally adheres to pharmacopoeia standards (<0.05 IU/mg), Topscience Biotech's Pharmaceutical Grade Sodium Hyaluronate maintains endotoxin levels at ≤0.001 IU/mg, merely 1/50 of the European Pharmacopoeia limit, demonstrating significant high-standard advantages.

The company possesses a comprehensive quality management system from raw material procurement through production processes to product release, providing safe and reliable high-quality supplies, offering downstream customers assured raw materials.

2. Sterile Breakthrough Overcomes Technological Bottleneck

"Sterility" is a critical threshold for the high-end application of sodium hyaluronate. By constructing and successfully operating China's first sterile sodium hyaluronate production line, Topscience Biotech broke through a long-standing technological bottleneck in this field domestically, achieving a milestone leap for the high-end application of sodium hyaluronate.

Different from "tested sterile," which relies on terminal inspection, Topscience Biotech practices "process sterile," controlled from the production source, representing true "sterility assurance."

Through sterilizing grade filtration throughout the process, its products can be directly used in downstream sterile preparations and medical device production, eliminating the need for terminal sterilization and ensuring product activity and safety.

3. Multi-Dimensional Strength Accelerates Global Layout

Topscience Biotech's comprehensive strength is built upon complete hardware facilities, robust R&D capabilities, and comprehensive global certifications. The company is equipped with 8 workshops compliant with GMP standards, laboratories meeting GLP standards, and possesses 6 provincial-level R&D platforms, having accumulated over 30 patents and 3 internationally advanced achievements. This not only lays a solid foundation for consolidating its market position but also accelerates the implementation of its internationalization strategy.

Tracing back Topscience Biotech's twenty-year development history, as early as 2015, the company successfully obtained the "EU CEP Certification" for its Sodium Hyaluronate API, thereby smoothly entering the European Union market. Starting from this point, Topscience Biotech continuously broke through in exploring international markets, accumulating more than 20 global certifications and gradually building a competitive advantage network covering the globe.

Topscience Biotech: The Path from Chinese Benchmark to Global Partner

Looking at Topscience Biotech's development over the past two decades, its goal extends far beyond being an excellent raw material supplier; it is also committed to being a co-builder of industry standards and a deep enabler of personalized customer solutions.

In the field of sodium hyaluronate raw materials, Topscience Biotech, relying on pharmaceutical-grade quality benchmarks, forward-looking R&D layout, and solid compliance qualifications, continuously provides global partners with long-term value that exceeds expectations.

Regarding internationalization, Topscience Biotech continuously promotes the upgrade of its market strategy from "breadth expansion" to "depth penetration." In the future, while consolidating existing markets such as the EU and Asia-Pacific, Topscience Biotech will actively explore emerging regions, further expanding its global business footprint, and delivering more high-standard, customized sodium hyaluronate solutions for the medical aesthetics and pharmaceutical industries.

At the technological innovation level, the company will continue to deeply cultivate the pharmaceutical application field, strengthen its technological advantages centered on Sterile Sodium Hyaluronate and Medical Device Grade Chondroitin Sulfate Sodium, consolidate its leading domestic position, and actively expand high-value-added, diversified bioactive material product lines.

Viewing Topscience Biotech's overall strategy, it has successfully transitioned from a basic supplier to a solutions partner. Through customized raw material solutions, professional technical support, and stable supply chain services, it effectively empowers partners to develop more market-competitive products.

Looking ahead, Topscience Biotech will continue to expand market breadth through global layout, build competitive depth through technological innovation, and gradually complete the value leap towards becoming a high-value-added strategic partner.

Gratitude for Walking Together, Embarking on a New Journey

Looking back on the twenty-year development journey, Topscience Biotech's achievements today are inseparable from the long-term trust of global customers, the collaborative efforts of partners, and the dedicated work of all employees. It is the convergence of these forces that has collectively propelled Topscience Biotech's continuous progress.

 Topscience Biotech always upholds the corporate philosophy of "creating benefits through service, winning reputation with quality," and engages with global partners with a more open and inclusive attitude to build a mutually beneficial industrial ecosystem. Currently, the company has established stable cooperation with numerous outstanding enterprises at home and abroad, which strongly testifies to Topscience Biotech's product strength and business credibility.

Looking to the future, Topscience Biotech will remain true to its original aspiration, join hands with all fellow travelers, and dedicate itself to promoting the progress and innovation of the pharmaceutical industry. Through continuous R&D exploration and industrial collaboration, it will contribute "Topscience Strength" to the cause of human health. We look forward to composing brilliant new chapters and forging a better future for the life sciences cause on the journey towards the next twenty years!